The instinct to consolidate testing with a single laboratory is understandable. One vendor relationship, one invoice, one point of contact. For a manufacturer with a simple product line and straightforward testing requirements, a single-lab strategy can work well. But as product portfolios grow and regulatory requirements become more complex, single-lab dependency creates risks that aren’t always visible until they become problems.
The choice between a single-lab and multi-lab testing strategy is one of the most consequential decisions a quality director makes. It affects testing quality, turnaround times, cost structure, regulatory defensibility, and operational resilience. Here’s how to think through it.
A single-lab strategy makes the most sense when your testing requirements are narrow and well-defined, and when a single laboratory genuinely has the accredited scope and validated methods to cover all of them. For a manufacturer with a small product line in a single category — say, a cosmetics company testing for microbial contamination, heavy metals, and preservative efficacy — a single accredited laboratory with validated methods for those specific tests may be the right answer.
The operational advantages are real. A single lab relationship means your team knows the lab’s processes, their turnaround times, their reporting formats, and their communication style. Onboarding new products is faster. Resolving disputes or questions about results is simpler. And if you’re managing testing volume carefully, a single lab may offer better pricing for consolidated business.
The risk is dependency. If your primary lab has a capacity issue, an equipment failure, or a personnel problem, your testing pipeline stops. If the lab loses accreditation for a specific test — which can happen during reassessment cycles — you have no backup. And if you’re in a regulated industry where FDA might scrutinize your testing program, a single lab that covers everything may not have the specialized depth that a regulator expects for complex tests.
Multi-lab testing strategies make sense in several situations that are common among mid-size and larger manufacturers.
Diverse product categories with different testing requirements. A company that makes dietary supplements, cosmetics, and food products faces different regulatory frameworks and different testing requirements for each category. The laboratory best suited for USP <61>/<62> microbial testing on supplements may not be the best choice for preservative efficacy testing on cosmetics or pathogen testing on food products. Specialization matters, and the best labs in each category tend to have deeper method validation and more experienced analysts than generalist labs.
High-volume testing that exceeds a single lab’s capacity. If you’re running 50+ batches per month across multiple product lines, a single laboratory may not be able to maintain consistent turnaround times without compromising queue management. Distributing volume across 2–3 labs with complementary capabilities can improve turnaround reliability and reduce the risk of bottlenecks during peak periods.
Regulatory requirements for method confirmation. Some regulatory contexts — particularly for products sold in multiple markets — require testing by more than one laboratory, or require that results from one laboratory be confirmed by a second. A multi-lab strategy makes this straightforward; a single-lab strategy requires building in a separate confirmation testing process.
Business continuity. For manufacturers where testing delays directly affect production schedules and revenue, having a qualified backup laboratory for critical tests is a form of operational insurance. The backup lab should be pre-qualified — scope verified, supplier questionnaire completed, at least one round of samples run — so you can activate them quickly if your primary lab has a problem.
Multi-lab strategies have real costs that don’t always show up in the initial analysis. Each laboratory relationship requires supplier qualification, annual scope review, and ongoing communication management. If you’re managing 4–5 lab relationships, that’s a meaningful administrative burden for a quality team.
Result interpretation becomes more complex when the same test is run at different laboratories. Slight differences in method execution, equipment calibration, and analyst technique can produce results that are technically within the method’s reproducibility range but look different on paper. Quality managers need to understand those differences and have a documented approach to resolving apparent discrepancies.
Data management is also more complex. If your LIMS (Laboratory Information Management System) or quality management software isn’t designed to handle results from multiple labs, you’ll end up managing data in spreadsheets — which creates its own quality and compliance risks.
Before choosing between single-lab and multi-lab strategies, answer these four questions:
Does a single laboratory hold ISO 17025 accreditation for all the tests I need, in my specific matrices? If no, a multi-lab strategy is likely necessary regardless of other factors.
What is my acceptable risk tolerance for testing delays? If a 2-week delay in testing results would halt production or miss a launch date, you need a backup lab strategy.
Do I have the internal resources to manage multiple lab relationships? Multi-lab management requires time and expertise. If your quality team is small, the operational overhead of managing 4–5 labs may outweigh the benefits.
What are my regulatory requirements for testing documentation? Some regulatory contexts require specific documentation of laboratory qualifications that is easier to maintain for a smaller number of labs.
For most mid-size manufacturers with diverse product lines, the answer is typically 2–3 primary laboratories with complementary specializations, plus at least one qualified backup for critical tests. That architecture balances specialization, operational resilience, and management overhead.
At Aurora TIC, our lab selection consulting service helps manufacturers design testing strategies that match their regulatory obligations, product portfolio, and operational capacity. The right architecture depends on specifics that vary by company — but the framework above is a reliable starting point for the analysis.